FDA Clearance Tracker · P890055-S073
3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and Accessories
Last checked: Nov 20, 2026Latest source record: Feb 7, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2020
Approved
Time to decision
29 days
Received Jan 9, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P890055-S073
- Device name
- 3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and Accessories
- Applicant
- Intera Oncology
- Applicant location
- Newton, MA
- Received
- Jan 9, 2020
- Decided
- Feb 7, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P890055
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Intera Oncology, Inc., 65 William Street, Suite 200, Wellesley, Massachusetts, to conduct quality system activities.
Source documents
Other decisions for Intera Oncology
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Intera Refill Kit510(k)
K213823 · Decided Mar 16, 2022 · 98 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.